Joseph Nolan
Directeur Général chez Jaguar Gene Therapy LLC
Fortune : 88 $ au 30/04/2024
Profil
Joseph Nolan is currently the President, Chief Executive Officer & Director at Jaguar Gene Therapy LLC.
Previously, he held positions as a Director at the Illinois Biotechnology Industry Organization and Axovia Therapeutics, Inc. He also served as an Independent Director at Athersys, Inc. from 2023 to 2024.
Additionally, Mr. Nolan was the President of Eversana Life Science Services LLC and the General Manager of Novartis Gene Therapies, Inc. He also worked as the Chief Commercial Officer & Senior Vice President at Marathon Pharmaceuticals LLC.
Mr. Nolan holds an MBA from the University of Notre Dame and an undergraduate degree from Tulane University (Louisiana).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATHERSYS, INC.
0,04% | 14/08/2023 | 21 951 ( 0,04% ) | 88 $ | 30/04/2024 |
Postes actifs de Joseph Nolan
| Sociétés | Poste | Début |
|---|---|---|
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Directeur Général | 01/03/2020 |
Anciens postes connus de Joseph Nolan
| Sociétés | Poste | Fin |
|---|---|---|
| ATHERSYS, INC. | Directeur/Membre du Conseil | 01/04/2024 |
| AVEXIS INC | Corporate Officer/Principal | - |
Axovia Therapeutics, Inc.
 Axovia Therapeutics, Inc. BiotechnologyHealth Technology Part of Axovia Therapeutics Ltd., Axovia Therapeutics, Inc. is dedicated to developing disease-transformative therapies that target key aspects of ciliopathies. The American company is working to advance gene therapy programs that have already shown early promise in treating some of the most severe aspects of bbs, such as early onset blindness and neurometabolic disease. The company was founded by Philip Beales, Victor Hernandez, and Philip Beales has been the CEO since incorporation. Axovia Therapeutics was acquired by Alsa Management Services Ltd on September 19, 2023. | Directeur/Membre du Conseil | - |
Eversana Life Science Services LLC
 Eversana Life Science Services LLC Miscellaneous Commercial ServicesCommercial Services EVERSANA Life Science Services LLC engages in the provision of global services to the life science industry. It offers pricing, reimbursement and market access, global channel management, revenue management, and affordability programs. The company is headquartered in Milwaukee, WI. | President | - |
Marathon Pharmaceuticals LLC
 Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Marathon Pharmaceuticals LLC is a holding company, which develops and manufactures pharmaceutical products. Its products include treatment for neurological disorders, rare cancers, and preanesthetics. The company was founded in 2008 and is headquartered in Northbrook, IL. | Corporate Officer/Principal | - |
Formation de Joseph Nolan
| University of Notre Dame | Masters Business Admin |
| Tulane University (Louisiana) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Illinois Biotechnology Industry Organization
 Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives. | Commercial Services |
Marathon Pharmaceuticals LLC
Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Marathon Pharmaceuticals LLC is a holding company, which develops and manufactures pharmaceutical products. Its products include treatment for neurological disorders, rare cancers, and preanesthetics. The company was founded in 2008 and is headquartered in Northbrook, IL. | Health Technology |
Eversana Life Science Services LLC
Eversana Life Science Services LLC Miscellaneous Commercial ServicesCommercial Services EVERSANA Life Science Services LLC engages in the provision of global services to the life science industry. It offers pricing, reimbursement and market access, global channel management, revenue management, and affordability programs. The company is headquartered in Milwaukee, WI. | Commercial Services |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Health Services |
Axovia Therapeutics, Inc.
Axovia Therapeutics, Inc. BiotechnologyHealth Technology Part of Axovia Therapeutics Ltd., Axovia Therapeutics, Inc. is dedicated to developing disease-transformative therapies that target key aspects of ciliopathies. The American company is working to advance gene therapy programs that have already shown early promise in treating some of the most severe aspects of bbs, such as early onset blindness and neurometabolic disease. The company was founded by Philip Beales, Victor Hernandez, and Philip Beales has been the CEO since incorporation. Axovia Therapeutics was acquired by Alsa Management Services Ltd on September 19, 2023. | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |